Valsartan Losartan and Irbesartan Products
| ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD., HUAHAI U.S. INC, PRINSTON PHARMACEUTICAL INC, SOLCO HEALTHCARE US LLC, TEVA PHARMACEUTICALS USA INC, TEVA PHARMACEUTICAL INDUSTRIES LTD, ACTAVIS LLC, HETERO USA INC, CAMBER PHARMACEUTICALS INC, HETERO DRUGS LTD, HETERO LABS LTD, TORRENT PHARMACEUTICALS LTD and TORRENT PHARMA INC |
| CONSUMER ECONOMIC LOSS PLAINTIFFS, THIRD-PARTY PAYOR PLAINTIFFS and MEDICAL MONITORING PLAINTIFFS |
| In re: IN RE: VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION |
| PRODUCT LIABILITY ADVISORY COUNCIL INC |
| 23-8005 |
| February 22, 2023 |
| U.S. Court of Appeals, Third Circuit |
| Other |
Docket Report
RSS Track this Docket
This docket was last retrieved on May 1, 2023. A more recent docket listing may be available from PACER.
| Document Text |
|---|
Filing 60
ORDER (SHWARTZ, MATEY and PHIPPS, Circuit Judges) The petitions for permission to appeal are DENIED. All pending motions are DISMISSED. Panel No.: CCO-053. Matey, Authoring Judge. [23-8005, 23-8006, 23-8007, 23-8008] (PDB) [Entered: 05/01/2023 04:15 PM]
|
| Filing 59 ECF FILER: Letter dated 04/24/2023 , filed pursuant to Rule 28(j) from counsel for Petitioners Huahai U.S. Inc, Prinston Pharmaceutical Inc, Solco Healthcare US LLC and Zhejiang Huahai Pharmaceutical Co., Ltd. in 23-8005. Service made by ECF. This document will be SENT TO THE MERITS PANEL, if/when applicable. [23-8008, 23-8005, 23-8006, 23-8007] (JD) [Entered: 04/24/2023 09:30 AM] |
| Filing 58 ECF FILER: Response filed by Respondent Medical Monitoring Plaintiffs in 23-8008, 23-8005, 23-8006, 23-8007 to motion to file response/reply, motion to file response/reply, motion to file response/reply, motion to file response/reply. Certificate of Service dated 04/04/2023. [23-8008, 23-8005, 23-8006, 23-8007] (NAM) [Entered: 04/04/2023 09:45 AM] |
| Filing 57 ECF FILER: Response filed by Respondents Consumer Economic Loss Plaintiffs and Third-Party Payor Plaintiffs in 23-8008, 23-8006, 23-8005, 23-8007 to motion to file response/reply, motion to file response/reply. Certificate of Service dated 03/31/2023. [23-8008, 23-8006, 23-8005, 23-8007] (RH) [Entered: 03/31/2023 06:35 PM] |
| Filing 56 ECF FILER: Motion filed by Petitioners Mylan laboratories Ltd, Mylan NV and Mylan Pharmaceuticals Inc in 23-8007 for leave to file a Reply to in Support of Petition for Permission to Appeal Pursuant to Federal Rule of Civil Procedure 23(f). Certificate of Service dated 03/30/2023. Service made by ECF. [23-8008, 23-8005, 23-8006, 23-8007] (CCT) [Entered: 03/30/2023 07:26 PM] |
| Filing 55 ECF FILER: Motion filed by Petitioner Cardinal Health Inc in 23-8008 for leave to file a Reply to Wholesaler Defendants' Petition for Permission to Appeal Pursuant to Federal Rule of Civil Procedure 23(f). Certificate of Service dated 03/30/2023. Service made by ECF, Email. [23-8008, 23-8005, 23-8006, 23-8007] (MSD) [Entered: 03/30/2023 06:08 PM] |
| Filing 54 ECF FILER: Motion filed by Petitioners Huahai U.S. Inc, Prinston Pharmaceutical Inc, Solco Healthcare US LLC and Zhejiang Huahai Pharmaceutical Co., Ltd. in 23-8005 for leave to file a Reply to PETITION FOR PERMISSION TO APPEAL ECONOMIC-LOSS CLASS CERTIFICATION RULINGS PURSUANT TO FEDERAL RULE OF CIVIL PROCEDURE 23(f). Certificate of Service dated 03/30/2023. Service made by ECF. [23-8005, 23-8006, 23-8007, 23-8008] (JD) [Entered: 03/30/2023 04:06 PM] |
| Filing 53 ECF FILER: Motion filed by Petitioners Huahai U.S. Inc, Zhejiang Huahai Pharmaceutical Co., Ltd., Prinston Pharmaceutical Inc and Solco Healthcare US LLC in 23-8005 for leave to file a Reply to PETITION FOR PERMISSION TO APPEAL MEDICAL MONITORING CLASS PURSUANT TO FEDERAL RULE OF CIVIL PROCEDURE 23(f). Certificate of Service dated 03/30/2023. Service made by ECF. [23-8005, 23-8006, 23-8007, 23-8008] (JD) [Entered: 03/30/2023 02:24 PM] |
| Filing 52 ECF FILER: Response filed by Respondent Medical Monitoring Plaintiffs in 23-8008, 23-8005, 23-8006, 23-8007 to original proceeding Petition Petition pursuant FRCP 23(f), original proceeding Petition Petition pursuant FRCP 23(f), original proceeding Petition Petition pursuant FRCP 23(f), original proceeding Petition Petition pursuant FRCP 23(f). Certificate of Service dated 03/23/2023. [23-8008, 23-8005, 23-8006, 23-8007] (NAM) [Entered: 03/23/2023 09:32 PM] |
| Filing 51 ECF FILER: DISCLOSURE STATEMENT on behalf of Maine Automobile Dealers Association, Inc. Insurance Trust. on behalf of Respondent Third-Party Payor Plaintiffs in 23-8008, 23-8005, 23-8006, 23-8007. [23-8008, 23-8005, 23-8006, 23-8007] (RH) [Entered: 03/23/2023 05:14 PM] |
| Filing 50 ECF FILER: DISCLOSURE STATEMENT on behalf of MSP Recovery Claims, Series LLC. on behalf of Respondent Third-Party Payor Plaintiffs in 23-8008, 23-8005, 23-8006, 23-8007. [23-8008, 23-8005, 23-8006, 23-8007] (RH) [Entered: 03/23/2023 05:13 PM] |
| Filing 49 ECF FILER: RESPONSE on behalf of Respondents Consumer Economic Loss Plaintiffs and Third-Party Payor Plaintiffs in 23-8008, 23-8005, 23-8006, 23-8007. Certificate of Service dated 03/23/2023 by ECF, Email. [23-8008, 23-8005, 23-8006, 23-8007]--[Edited 03/24/2023 by PDB] (RH) [Entered: 03/23/2023 05:11 PM] |
| Filing 48 ECF FILER: DISCLOSURE STATEMENT on behalf of Petitioner Camber Pharmaceuticals Inc in 23-8005.--[Edited 03/13/2023 by PDB] (WHS) [Entered: 03/10/2023 02:54 PM] |
| Filing 47 ECF FILER: ENTRY OF APPEARANCE from Andrew F. Albero on behalf of Petitioner(s) The Kroger Co.. [23-8005, 23-8006, 23-8007, 23-8008] (AA) [Entered: 03/10/2023 02:43 PM] |
| Filing 46 ECF FILER: ENTRY OF APPEARANCE from Andrew F. Albero on behalf of Petitioner(s) Camber Pharmaceuticals, Inc.. [23-8005, 23-8006, 23-8007, 23-8008] (AA) [Entered: 03/10/2023 02:42 PM] |
| Filing 44 ECF FILER: ENTRY OF APPEARANCE from Walter H. Swayze, III on behalf of Petitioner(s) Camber Pharmaceuticals, Inc.--[Edited 03/10/2023 by PDB] (WHS) [Entered: 03/10/2023 02:18 PM] |
| Filing 43 ECF FILER: ENTRY OF APPEARANCE from Lori G. Cohen on behalf of Petitioner(s) Teva Pharmaceutical Industries Ltd.; Teva Pharmaceuticals USA, Inc.; Actavis LLC; Actavis Pharma, Inc.. [23-8005] (LGC) [Entered: 03/10/2023 11:57 AM] |
| Filing 42 ECF FILER: DISCLOSURE STATEMENT on behalf of Actavis Pharma, Inc.. [23-8005, 23-8006, 23-8007, 23-8008] (GEO) [Entered: 03/09/2023 06:59 PM] |
| Filing 41 ECF FILER: DISCLOSURE STATEMENT on behalf of Petitioner Actavis LLC in 23-8005. [23-8005, 23-8006, 23-8007, 23-8008] (GEO) [Entered: 03/09/2023 06:52 PM] |
| Filing 40 ECF FILER: DISCLOSURE STATEMENT on behalf of Petitioner Teva Pharmaceuticals USA Inc in 23-8005. [23-8005, 23-8006, 23-8007, 23-8008] (GEO) [Entered: 03/09/2023 06:48 PM] |
| Filing 39 ECF FILER: DISCLOSURE STATEMENT on behalf of Petitioner Teva Pharmaceutical Industries Ltd in 23-8005. [23-8005, 23-8006, 23-8007, 23-8008] (GEO) [Entered: 03/09/2023 06:46 PM] |
| Filing 38 ECF FILER: DISCLOSURE STATEMENT on behalf of.. on behalf of Petitioner Actavis LLC in 23-8005. [23-8005, 23-8006, 23-8007, 23-8008] (GEO) [Entered: 03/09/2023 06:45 PM] |
| Filing 37 ECF FILER: ENTRY OF APPEARANCE from Gregory E. Ostfeld on behalf of Petitioner(s) Teva Pharmaceutical Industries Ltd.; Teva Pharmaceuticals USA, Inc.; Actavis LLC; Actavis Pharma, Inc.. [23-8005, 23-8006, 23-8007, 23-8008] (GEO) [Entered: 03/09/2023 06:41 PM] |
| Filing 36 ECF FILER: ENTRY OF APPEARANCE from Ellie Norris (aka Elizabeth Norris) on behalf of Petitioner(s) McKesson Corporation. [23-8008, 23-8005, 23-8006, 23-8007] (EN) [Entered: 03/09/2023 03:41 PM] |
| Filing 35 ECF FILER: ENTRY OF APPEARANCE from Geraldine W. Young on behalf of Petitioner(s) McKesson Corporation. [23-8008, 23-8005, 23-8006, 23-8007] (GY) [Entered: 03/09/2023 03:37 PM] |
| Filing 34 ECF FILER: ENTRY OF APPEARANCE from Clem C. Trischler on behalf of Petitioner(s) Mylan Laboratories Ltd., Mylan Pharmaceuticals Inc., and Mylan N.V.. [23-8008, 23-8005, 23-8006, 23-8007] (CCT) [Entered: 03/09/2023 03:20 PM] |
| Filing 33 ECF FILER: ENTRY OF APPEARANCE from Darryl W. Anderson on behalf of Petitioner(s) McKesson Corporation. [23-8008, 23-8005, 23-8006, 23-8007] (DA) [Entered: 03/09/2023 03:09 PM] |
| Filing 32 ECF FILER: ENTRY OF APPEARANCE from D'Lesli M. Davis on behalf of Petitioner(s) McKesson Corporation. [23-8008, 23-8005, 23-8006, 23-8007] (DMD) [Entered: 03/09/2023 02:48 PM] |
| Filing 28 ECF FILER: DISCLOSURE STATEMENT on behalf of Petitioner Hetero Labs Ltd. [23-8005] (EIA) [Entered: 03/08/2023 12:39 PM] |
| Filing 27 ECF FILER: DISCLOSURE STATEMENT on behalf of Petitioner Hetero Drugs Ltd. [23-8005] (EIA) [Entered: 03/08/2023 12:37 PM] |
| Filing 26 ECF FILER: ENTRY OF APPEARANCE from Eric I. Abraham, Esq. on behalf of Petitioner(s) Hetero Drugs Ltd. and Hetero Labs Ltd.. [23-8005] (EIA) [Entered: 03/08/2023 12:35 PM] |
| Filing 24 ECF FILER: DISCLOSURE STATEMENT on behalf of Petitioner Hetero USA Inc in 23-8005. [23-8005, 23-8006, 23-8007, 23-8008] (JLP) [Entered: 03/08/2023 08:42 AM] |
| Filing 23 ECF FILER: ENTRY OF APPEARANCE from Janet L. Poletto on behalf of Petitioner(s) Hetero USA Inc..--[Edited 03/08/2023 by PDB] (JLP) [Entered: 03/08/2023 08:39 AM] |
| Filing 22 ECF FILER: DISCLOSURE STATEMENT on behalf of Petitioner Zhejiang Huahai Pharmaceutical Co., Ltd.. [23-8005] (JD) [Entered: 03/07/2023 11:16 PM] |
| Filing 21 ECF FILER: DISCLOSURE STATEMENT on behalf of Petitioner Solco Healthcare US LLC. [23-8005] (JD) [Entered: 03/07/2023 11:16 PM] |
| Filing 20 ECF FILER: DISCLOSURE STATEMENT on behalf of Petitioner Prinston Pharmaceutical Inc. [23-8005] (JD) [Entered: 03/07/2023 11:15 PM] |
| Filing 19 ECF FILER: DISCLOSURE STATEMENT on behalf of Petitioner Huahai U.S. Inc. [23-8005] (JD) [Entered: 03/07/2023 11:14 PM] |
| Filing 18 ECF FILER: ENTRY OF APPEARANCE from Jessica Davidson on behalf of Petitioner(s) Zhejiang Huahai Pharmaceutical Co., Ltd., Huahai U.S., Inc., Prinston Pharmaceutical Inc., and Solco Healthcare U.S., LLC. [23-8005] (JD) [Entered: 03/07/2023 11:03 PM] |
| Filing 17 ECF FILER: DISCLOSURE STATEMENT on behalf of Petitioner Torrent Pharmaceuticals Ltd. [23-8005] (ARB) [Entered: 03/07/2023 05:23 PM] |
| Filing 16 ECF FILER: DISCLOSURE STATEMENT on behalf of Petitioner Torrent Pharma Inc. [23-8005] (ARB) [Entered: 03/07/2023 05:22 PM] |
| Filing 14 ECF FILER: ENTRY OF APPEARANCE from Alexia R. Brancato on behalf of Petitioner(s) Torrent Pharma Inc. and Torrent Pharmaceuticals, Ltd.. [23-8005] (ARB) [Entered: 03/07/2023 05:18 PM] |
| Filing 11 ECF FILER: ENTRY OF APPEARANCE from Jay P. Lefkowitz on behalf of Petitioner(s) Torrent Pharma Inc. and Torrent Pharmaceuticals, Ltd.. [23-8005] (JPL) [Entered: 03/07/2023 05:12 PM] |
| Filing 10 ECF FILER: ENTRY OF APPEARANCE from Devora W. Allon on behalf of Petitioner(s) Torrent Pharma Inc. and Torrent Pharmaceuticals, Ltd.. [23-8005] (DWA) [Entered: 03/07/2023 05:11 PM] |
| Filing 7 TEXT ONLY ORDER (Clerk) granting Motion for Extension of Time to File Response to Petition for Permission to Appeal under Rule 23(f) filed by Respondents Consumer Economic Loss Plaintiffs, Third-Party Payor Plaintiffs and Medical Monitoring Plaintiffs. Respondents' response to the petitions for permission to appeal must be filed on or before March 23, 2023. [23-8005, 23-8006, 23-8007, 23-8008] (DW) [Entered: 03/07/2023 11:39 AM] |
| Filing 6 ECF FILER: Motion filed by Product Liability Advisory Council, Inc. to proceed as amicus on the merits in support of Appellant/Petitioner. Certificate of Service dated 03/01/2023. [23-8005, 23-8006, 23-8007, 23-8008] (THD) [Entered: 03/01/2023 04:54 PM] |
| Filing 5 ECF FILER: ENTRY OF APPEARANCE from Thomas H. Dupree Jr. on behalf of Amicus Curiae Product Liability Advisory Council, Inc.. [23-8005, 23-8006, 23-8007, 23-8008] (THD) [Entered: 03/01/2023 03:37 PM] |
| Filing 3 ECF FILER: Motion filed by Respondents Consumer Economic Loss Plaintiffs, Medical Monitoring Plaintiffs and Third-Party Payor Plaintiffs in 23-8008, 23-8005, Respondents Consumer Economic Loss Plaintiffs and Third-Party Payor Plaintiffs in 23-8006, 23-8007 for Extension of Time to file Response to Defendants-Petitioners' Petitions for Permission to Appeal under Rule 23(f) until/for 14 days, or until March 23, 2023. Certificate of Service dated 02/27/2023. Service made by ECF, Email. [23-8008, 23-8005, 23-8006, 23-8007] (RH) [Entered: 02/27/2023 07:05 PM] |
| Filing 2 CLERK ORDER Several defendants have filed four petitions for permission to appeal the districtFebruary 8, 2023, order regarding class certification. These petitions are consolidated so they will be considered together by a panel of this Court. It appears that class certification was sought by three groups of plaintiffs. To facilitate electronic filing for large groups of similarly situated parties represented by the same counsel, this Court's dockets will designate each group of plaintiffs as follows. Counsel is advised that these designated filers are for CM/ECF filing purposes only. Names of all represented parties must be listed on all forms, motions, and briefs. Any response(s) to these four petitions must be filed on or before March 9, 2023. Similarly situated parties are encouraged to file a single consolidated response addressing all petitions. The Court disfavors redundant submissions. If the Consumer Economic Loss Plaintiffs, Third-Party Payor Plaintiffs, or Medical Monitoring Plaintiffs want to respond to these petitions, a maximum of one response for each group may be filed. The pharmacies' petition at No. 23-8006 did not contain proof of service as required by Federal Rule of Appellate Procedure 25(d)(1)(a). Those petitioners must file a certification of service within three days of this order. The $500 fee paid by the NDEA petitioners for No. 23-8007 has been refunded. No fee is required unless this Court grants permission to appeal. [23-8008, 23-8005, 23-8006, 23-8007] (PDB) [Entered: 02/24/2023 02:04 PM] |
| Filing 1 Petition for Leave to Appeal pursuant to Fed. R. Civ. P. 23(f) filed by Petitioners Actavis LLC, Camber Pharmaceuticals Inc, Hetero Drugs Ltd, Hetero Labs Ltd, Hetero USA Inc, Huahai U.S. Inc, Prinston Pharmaceutical Inc, Solco Healthcare US LLC, Teva Pharmaceutical Industries Ltd, Teva Pharmaceuticals USA Inc, Torrent Pharma Inc, Torrent Pharmaceuticals Ltd and Zhejiang Huahai Pharmaceutical Co., Ltd.. Received on 02/22/2023. Certificate of Service dated 02/22/2023. Service made by US mail. (PDB) [Entered: 02/24/2023 12:07 PM] |
Access additional case information on PACER
Access the Case Summary and Docket Report to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
